Testing Treatment for Prostate Cancer
common.study.values.description
“Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer”
The purpose of this study is to compare the effects of ablative therapy (radiation or surgery) to all sites of disease combined with standard treatments on prostate cancer, compared to the standard or usual treatments used to treat this disease.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
Radiation - Ablative Radiation Therapy
Undergo stereotactic radiotherapy and/or surgery to all sites of disease (oligometastases and primary prostate if previously untreated).
Standard of care
Patients continue to receive their current planned systemic therapy at the discretion of the treating physician
participant.views.study.view.additional
participant.views.study.view.scientific-title
A Randomized Phase III Trial of Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer [PLATON]
common.study.values.clinical-trial-id
NCT03784755
participant.views.study.view.id
aOYqgd
